These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2566903)

  • 1. Characterization of dopamine receptor subtypes by comparative structure-activity relationships: dopaminomimetic activities and solid state conformation of monohydroxy-1,2,3,4,4a,5,10,10a-octahydrobenz[g]quinolines and its implications for a rotamer-based dopamine receptor model.
    Seiler MP; Markstein R; Walkinshaw MD; Boelsterli JJ
    Mol Pharmacol; 1989 May; 35(5):643-51. PubMed ID: 2566903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
    J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina.
    Hensler JG; Cotterell DJ; Dubocovich ML
    J Pharmacol Exp Ther; 1987 Dec; 243(3):857-67. PubMed ID: 2961878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. II. Pharmacological studies with derivatives of 2-aminotetralin, benzhydro[f]quinoline, benzhydro[g]quinoline, apomorphine and clonidine suggest a pharmacological dissimilarity between peripheral presynaptic dopamine receptors and alpha-2 adrenoceptors.
    Maixner W; Flynn JR; Arnerić SP; Cannon JG; Long JP
    J Pharmacol Exp Ther; 1983 Feb; 224(2):352-8. PubMed ID: 6296357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 receptor agonists: an analysis of indirect models.
    Johansson AM; Grol CJ; Karlén A; Hacksell U
    Drug Des Discov; 1994 Feb; 11(2):159-74. PubMed ID: 7915550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 10-substituted 11-oxygenated (R)-aporphines: synthesis, pharmacology, and modeling of 5-HT1A receptor interactions.
    Hedberg MH; Jansen JM; Nordvall G; Hjorth S; Unelius L; Johansson AM
    J Med Chem; 1996 Aug; 39(18):3491-502. PubMed ID: 8784447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of alpha- and beta-rotameric forms of 2-substituted octahydrobenzo[f]quinoline dopamine congeners with high and low affinity states of the anterior pituitary dopamine receptor and prolactin inhibition.
    Findell PR; Torkelson SM; Craig JC; Weiner RI
    Mol Pharmacol; 1988 Jan; 33(1):78-83. PubMed ID: 3336350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and dopamine receptor binding of 4-(2-aminoethyl)-1H-pyrazole and its N,N-dialkyl derivatives.
    Claudi F; Giorgioni G; Di Stefano A; Cagnotto A; Skorupska M
    Drug Des Discov; 1993; 10(1):57-64. PubMed ID: 8104517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
    Loew GH; Lawson JA; Uyeno ET; Toll L; Frenking G; Polgar W; Ma LY; Camerman N; Camerman A
    Mol Pharmacol; 1988 Sep; 34(3):363-76. PubMed ID: 2843751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic 2-aminotetralins: affinities for dopamine D2-receptors, molecular structures, and conformational preferences.
    Johansson AM; Karlén A; Grol CJ; Sundell S; Kenne L; Hacksell U
    Mol Pharmacol; 1986 Sep; 30(3):258-69. PubMed ID: 2943981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity.
    Si YG; Gardner MP; Tarazi FI; Baldessarini RJ; Neumeyer JL
    J Med Chem; 2008 Feb; 51(4):983-7. PubMed ID: 18251489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
    López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
    J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenyliminoimidazolidines. Characterization of a class of potent agonists of octopamine-sensitive adenylate cyclase and their use in understanding the pharmacology of octopamine receptors.
    Nathanson JA
    Mol Pharmacol; 1985 Sep; 28(3):254-68. PubMed ID: 2993848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptors.
    Schoffelmeer AN; Hogenboom F; Mulder AH; Ronken E; Stoof JC; Drukarch B
    Synapse; 1994 Jul; 17(3):190-5. PubMed ID: 7974202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel synthesis and pharmacological evaluation of a potential dopamine D1/D2 agonist: 1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline-6,7-diol.
    Liu D; Dijkstra D; de Vries JB; Wikström HV
    Bioorg Med Chem; 2008 Mar; 16(6):3438-44. PubMed ID: 18313303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping.
    Mottola DM; Laiter S; Watts VJ; Tropsha A; Wyrick SD; Nichols DE; Mailman RB
    J Med Chem; 1996 Jan; 39(1):285-96. PubMed ID: 8568818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.